Healthcare: Frustrating Flops, Plus Welcome to the Wrinkle Wars
Industry Focus - Podcast tekijän mukaan The Motley Fool
Kategoriat:
What Gilead Sciences and Sangamo Therapeutics disappointing data means to investors and why Allergan may face a formidable foe in up-and-comer Evolus. Stocks: GILD, SGMO, AGN, EOLS
